Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-14
DOI
10.1038/s41467-020-18245-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release
- (2019) Shu Lian et al. EBioMedicine
- First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
- (2019) Branimir I. Sikic et al. JOURNAL OF CLINICAL ONCOLOGY
- Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
- (2019) Ivan Perrot et al. Cell Reports
- HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity
- (2019) Shiying Wu et al. NATURE CELL BIOLOGY
- Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system
- (2019) Claire Lhuillier et al. Genome Medicine
- Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
- (2018) Annemarie E.M. Post et al. CLINICAL CANCER RESEARCH
- SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy
- (2018) André Veillette et al. TRENDS IN IMMUNOLOGY
- Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
- (2018) Ariel E. Marciscano et al. Journal for ImmunoTherapy of Cancer
- Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway
- (2018) Marco Durante et al. Frontiers in Oncology
- Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling
- (2017) Meng Michelle Xu et al. IMMUNITY
- The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
- (2017) Hanke L. Matlung et al. IMMUNOLOGICAL REVIEWS
- Radiotherapy and immunotherapy: a beneficial liaison?
- (2017) Ralph R. Weichselbaum et al. Nature Reviews Clinical Oncology
- A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
- (2017) Paola A. Betancur et al. Nature Communications
- Intercellular Communication of Tumor Cells and Immune Cells after Exposure to Different Ionizing Radiation Qualities
- (2017) Sebastian Diegeler et al. Frontiers in Immunology
- Endoplasmic Reticulum Stress Protein GRP78 Modulates Lipid Metabolism to Control Drug Sensitivity and Antitumor Immunity in Breast Cancer
- (2016) Katherine L. Cook et al. CANCER RESEARCH
- The value of adjuvant radiotherapy on survival and recurrence in triple-negative breast cancer: A systematic review and meta-analysis of 5507 patients
- (2016) M.A. O’Rorke et al. CANCER TREATMENT REVIEWS
- ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
- (2016) Junjian Wang et al. NATURE MEDICINE
- Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
- (2016) Michael B. Bernstein et al. Nature Reviews Clinical Oncology
- Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy
- (2016) Akanksha Chhabra et al. Science Translational Medicine
- A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer
- (2016) Sukhbir Kaur et al. Oncotarget
- NF-κB functions as a molecular link between tumor cells and Th1/Tc1 T cells in the tumor microenvironment to exert radiation-mediated tumor suppression
- (2016) Priscilla S. Simon et al. Oncotarget
- The NF-κB Pathway and Cancer Stem Cells
- (2016) Amanda Rinkenbaugh et al. Cells
- CD47 Receptor Globally Regulates Metabolic Pathways That Control Resistance to Ionizing Radiation
- (2015) Thomas W. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial
- (2015) Encouse B Golden et al. LANCET ONCOLOGY
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- Opportunities and challenges of radiotherapy for treating cancer
- (2015) Dörthe Schaue et al. Nature Reviews Clinical Oncology
- CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy
- (2014) D. R. Soto-Pantoja et al. CANCER RESEARCH
- Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy
- (2014) Ann Rita Halvorsen et al. INTERNATIONAL JOURNAL OF CANCER
- Frontiers in Radiotherapy for Early-Stage Invasive Breast Cancer
- (2014) Christine M. Fisher et al. JOURNAL OF CLINICAL ONCOLOGY
- Post-mastectomy radiotherapy reduces recurrence and mortality
- (2014) Roberto Orecchia Nature Reviews Clinical Oncology
- The role of CUX1 in antagonizing NF-κB signaling in TAMs
- (2014) Benjamin Kühnemuth et al. OncoImmunology
- Targeting tumor-infiltrating macrophages to combat cancer
- (2013) Roheena Z Panni et al. Immunotherapy
- Radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer
- (2013) Daniel W. Vermeer et al. INTERNATIONAL JOURNAL OF CANCER
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
- (2013) Silvia C. Formenti et al. JNCI-Journal of the National Cancer Institute
- An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer
- (2013) E. B. Golden et al. Cancer Immunology Research
- Optimizing Cancer Treatments to Induce an Acute Immune Response: Radiation Abscopal Effects, PAMPs, and DAMPs
- (2012) C. M. Ludgate CLINICAL CANCER RESEARCH
- HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells
- (2012) N. Duru et al. CLINICAL CANCER RESEARCH
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma
- (2012) B. Edris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- γ-Radiation Promotes Immunological Recognition of Cancer Cells through Increased Expression of Cancer-Testis Antigens In Vitro and In Vivo
- (2011) Anu Sharma et al. PLoS One
- CD47-signal regulatory protein- (SIRP ) interactions form a barrier for antibody-mediated tumor cell destruction
- (2011) X. W. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
- (2010) SaeGwang Park et al. CANCER CELL
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
- (2009) L. Liu et al. CANCER RESEARCH
- Radioprotection in Normal Tissue and Delayed Tumor Growth by Blockade of CD47 Signaling
- (2009) J. B. Maxhimer et al. Science Translational Medicine
- Effect of Lapatinib on the Outgrowth of Metastatic Breast Cancer Cells to the Brain
- (2008) B. Gril et al. JNCI-Journal of the National Cancer Institute
- NF-κB-MediatedHER2Overexpression inRadiation-Adaptive Resistance
- (2008) Ning Cao et al. RADIATION RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started